Search results for "Non-Steroidal"

showing 10 items of 286 documents

The preclinical pharmacology of roflumilast--a selective, oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary disease

2009

After more than two decades of research into phosphodiesterase 4 (PDE4) inhibitors, roflumilast (3-cyclopropylmethoxy-4-difluoromethoxy-N-[3,5-di-chloropyrid-4-yl]-benzamide) may become the first agent in this class to be approved for patient treatment worldwide. Within the PDE family of 11 known isoenzymes, roflumilast is selective for PDE4, showing balanced selectivity for subtypes A-D, and is of high subnanomolar potency. The active principle of roflumilast in man is its dichloropyridyl N-oxide metabolite, which has similar potency as a PDE4 inhibitor as the parent compound. The long half-life and high potency of this metabolite allows for once-daily, oral administration of a single, 500…

CyclopropanesPulmonary and Respiratory MedicinePhosphodiesterase Inhibitorsmedicine.drug_classDrug Evaluation PreclinicalAdministration OralAminopyridinesInflammationPharmacologyPulmonary Disease Chronic ObstructiveCOPD; Inflammation; Oral therapy; Phosphodiesterase 4; Preclinical pharmacology; RoflumilastBronchodilatormedicineAnimalsHumansCOPDPharmacology (medical)RoflumilastPhosphodiesterase 4InflammationCOPDLungOral therapybusiness.industryAnti-Inflammatory Agents Non-SteroidalBiochemistry (medical)medicine.diseasePulmonary hypertensionObstructive lung diseasemedicine.anatomical_structureTolerabilityBenzamidesImmunologyPhosphodiesterase 4 InhibitorsPreclinical pharmacologymedicine.symptombusinessRoflumilastmedicine.drug
researchProduct

The effects of ibuprofen on activated sludge: Shift in bacterial community structure and resistance to ciprofloxacin

2017

Abstract Ibuprofen (IBP) is ranked at the 4th place among 57 pharmaceutical compounds according to the number of citations in prioritization documents. The response of microbial community of activated sludge to IBP was studied at the concentrations of 50–5000 mg/L. Batch incubation was performed in an OxiTop® device for 21 days. The reduction of biological oxygen demand depended on the IBP concentration and varied in the range from 321 to 107 mg O 2 /L. Massive DNA sequencing analysis of the activated sludge revealed that Proteobacteria became more dominant when grown in the presence of IBP. Microbial diversity was reduced in the presence of 500–1000 mg/L IBP, but increased again in the pre…

DNA Bacterial0301 basic medicineEnterobacterialesBiochemical oxygen demandEnvironmental EngineeringHealth Toxicology and Mutagenesis030106 microbiologyIbuprofen010501 environmental sciences01 natural sciencesMicrobiology03 medical and health sciencesCiprofloxacinRNA Ribosomal 16SmedicineEnvironmental ChemistryFood scienceWaste Management and DisposalIncubation0105 earth and related environmental sciencesBiological Oxygen Demand AnalysisBacteriaSewagebiologyAnti-Inflammatory Agents Non-SteroidalDrug Resistance Microbialbiology.organism_classificationPollutionAnti-Bacterial AgentsCiprofloxacinActivated sludgeMicrobial population biologyProteobacteriaWater Pollutants ChemicalBacteriamedicine.drugJournal of Hazardous Materials
researchProduct

Inhibition of pro-inflammatory enzymes by inuviscolide, a sesquiterpene lactone from Inula viscosa

2006

Abstract This work concerns the pharmacological activity of inuviscolide, a sesquiterpenoid from Inula viscosa. It exerts inhibitory effects on elastase, cyclooxygenase 1 and secretory phospholipase A2. Furthermore, it reduces the skin leukocyte infiltration in a murine model of dermatitis induced by repeated application of 12-O-tetradecanoylphorbol 13-acetate.

DermatitisBiologyPharmacognosyPharmacologySesquiterpene lactoneSesquiterpeneLactonesMicechemistry.chemical_compoundDrug DiscoveryLeukocytesAnimalsHumansEnzyme InhibitorsPharmacologychemistry.chemical_classificationPancreatic Elastaseintegumentary systemPlant ExtractsAnti-Inflammatory Agents Non-SteroidalElastaseBiological activityGeneral MedicineEnzymechemistryBiochemistrybiology.proteinTetradecanoylphorbol AcetateInulaCyclooxygenaseSesquiterpenesLactonePhytotherapyFitoterapia
researchProduct

Hepatic metabolism of diclofenac: role of human CYP in the minor oxidative pathways.

1999

The aim of this study was to re-examine the human hepatic metabolism of diclofenac, with special focus on the generation of minor hydroxylated metabolites implicated in the idiosyncratic hepatotoxicity of the drug. Different experimental approaches were used: human hepatocytes, human microsomes, and engineered cells expressing single human CYP (cytochromes P450). Human hepatocytes formed 3'-hydroxy-, 4'-hydroxy-, 5-hydroxy- 4',5-dihydroxy-, and N,5-dihydroxydiclofenac, as well as several lactams. Formation of 4'- and 5-hydroxydiclofenac by human liver microsomes followed a Michaelis-Menten kinetics (Km 9 +/- 1 microM; Vmax 432 +/- 15 pmol/min/mg and Km 43 +/- 5 microM; and Vmax 15.4 +/- 0.6…

DiclofenacMetaboliteIn Vitro TechniquesBiochemistryCell LineHydroxylationCytochrome P-450 CYP2C8chemistry.chemical_compoundTolbutamideCytochrome P-450 Enzyme SystemmedicineHumansBiotransformationCytochrome P-450 CYP2C9PharmacologybiologyAnti-Inflammatory Agents Non-SteroidalCytochrome P450Metabolismmedicine.anatomical_structureBiochemistrychemistrySteroid 16-alpha-HydroxylaseHepatocyteSteroid HydroxylasesMicrosomebiology.proteinMicrosomes LiverAryl Hydrocarbon HydroxylasesOxidation-ReductionDrug metabolismmedicine.drug
researchProduct

The pyrrole moiety as a template for COX-1/COX-2 inhibitors

2000

Aroyl- and thiophene-substituted pyrrole derivatives have been synthesized as a new class of COX-1/COX-2 inhibitors. The inhibition of COX-1 was evaluated in a biological system using bovine PMNLs as the enzyme source, whereas LPS-stimulated human monocytes served as the enzyme source for inducible COX-2. The determination of the concentration of arachidonic acid metabolites was performed by HPLC for COX-1 and RIA for COX-2. Variation of the substitution pattern led to a series of active compounds which showed inhibition for COX-1 and COX-2. Structural requirements for the development of COX-1/COX-2 inhibitors are discussed.

DiclofenacNeutrophilsStereochemistryIndomethacinThiophenesHigh-performance liquid chromatographyMonocytesPyrrole derivativeschemistry.chemical_compoundDrug DiscoveryAnimalsHumansStructure–activity relationshipMoietyCyclooxygenase InhibitorsPyrrolesSulfonesPyrrolePharmacologychemistry.chemical_classificationArachidonic AcidCyclooxygenase 2 InhibitorsMolecular StructureAnti-Inflammatory Agents Non-SteroidalOrganic ChemistryMembrane ProteinsGeneral MedicineIsoenzymesEnzymechemistryMembrane proteinBiochemistryCyclooxygenase 2Prostaglandin-Endoperoxide SynthasesCyclooxygenase 1Leukocytes MononuclearCattleArachidonic acidEuropean Journal of Medicinal Chemistry
researchProduct

Hydroxypropylmethylcellulose films for the ophthalmic delivery of diclofenac sodium

2012

Abstract Objectives The aim of this study was to prepare diclofenac/hydroxypropylmethylcellulose (HPMC) and diclofenac-loaded nanoparticles/HPMC films as potential systems for ocular delivery. Methods Two different concentration of the polymer were used: 1.5 and 2.0% w/v. Chitosan–hyaluronic acid nanoparticles were prepared by the ionotropic gelation technique. Nanoparticles were characterized by transmission electron microscopy, dynamic light scattering, drug encapsulation efficiency and rheological studies. In-vitro drug studies and corneal penetration release studies were carried out. Drug release mechanism was finally evaluated by fitting the Ritger and Peppas equation to data. In addit…

DiclofenacPolymersPharmaceutical ScienceNanoparticleAdministration OphthalmicMethylcellulosePharmacologyPermeabilityDosage formDrug Delivery SystemsHypromellose DerivativesDiclofenacDynamic light scatteringmedicineHyaluronic AcidDosage FormsPharmacologychemistry.chemical_classificationChitosanChemistryAnti-Inflammatory Agents Non-SteroidalDiclofenac SodiumPolymerPermeationHypromellose DerivativesNanoparticlesmedicine.drugNuclear chemistryJournal of Pharmacy and Pharmacology
researchProduct

Inhibition of skin inflammation in mice by diclofenac in vesicular carriers: Liposomes, ethosomes and PEVs

2013

Diclofenac-loaded phospholipid vesicles, namely conventional liposomes, ethosomes and PEVs (penetration enhancer-containing vesicles) were developed and their efficacy in TPA (phorbol ester) induced skin inflammation was examined. Vesicles were made from a cheap and unpurified mixture of phospholipids and diclofenac sodium; Transcutol P and propylene glycol were added to obtain PEVs, and ethanol to produce ethosomes. The structure and lamellar organization of the vesicle bilayer were investigated by transmission electron microscopy and small and wide angle X-ray scattering, as well as the main physico-chemical features. The formulations, along with a diclofenac solution and commercial Volta…

DiclofenacSurface PropertiesDrug CompoundingSkin AbsorptionLipid BilayersPharmaceutical ScienceIn Vitro TechniquesDermatitis ContactMiceDiclofenacMicroscopy Electron TransmissionX-Ray DiffractionmedicineAnimalsSkinDrug CarriersLiposomeChromatographyEthanolChemistryBilayerVesicleAnti-Inflammatory Agents Non-SteroidalDiclofenac SodiumPenetration (firestop)PermeationPropylene GlycolLiposomesBiophysicsNanoparticlesNanocarriersmedicine.drugInternational Journal of Pharmaceutics
researchProduct

Synthesis and comparison of the antiinflammatory activity of manoalide and cacospongionolide B analogues.

1998

We have synthesized analogues of two naturally occurring antiinflammatory marine compounds, manoalide and cacospongionolide B, containing a pyranofuranone moiety which is considered the pharmacophoric group. The two compounds, and hence their analogues, differ in the presence or absence in the dihydropyran ring of an hemiacetal function which was considered essential to irreversibly inactivate phospholipase A 2 (PLA 2 ). The two series of compounds were tested for their inhibitory effects on secretory PLA 2 belonging to the groups I, II, and III, and the activities were found to be similar in both series, irrespective of the presence or absence of the additional hemiacetal function. In addi…

DihydropyranStereochemistrySwineCarrageenanChemical synthesisPhospholipases ACell Linechemistry.chemical_compoundManoalideMiceStructure-Activity RelationshipCytosol4-ButyrolactoneDrug DiscoveryMoietyAnimalsEdemaHumansEnzyme InhibitorsPancreasPyranschemistry.chemical_classificationElapid VenomsPhospholipase AbiologyMolecular StructureTerpenesAnti-Inflammatory Agents Non-SteroidalSynovial MembraneBee VenomsKineticsPhospholipases A2chemistryEnzyme inhibitorDrug Designbiology.proteinMolecular MedicineHemiacetalFemaleLactoneJournal of medicinal chemistry
researchProduct

Evaluation of the pH effect of formulations on the skin permeability of drugs by biopartitioning micellar chromatography☆

2004

Dermal absorption of chemicals is an area of increasing interest for the pharmaceutical and cosmetic industries, as well as in dermal exposure and risk assessment processes. Biopartitioning micellar chromatography (BMC) is a mode of reversed phase micellar chromatography that has proved to be useful in the description and prediction of several pharmacological properties of xenobiotics including oral drug absorption, ocular and skin drug permeability. The present paper deals with the application of biopartitionig micellar chromatography to evaluate the pH effect on the skin permeability of twelve non-steroidal anti-inflammatory drugs and lidocaine. For this purpose the BMC retention of the w…

Dosage FormsKetoprofenChromatographyChemistrySkin AbsorptionAnti-Inflammatory Agents Non-SteroidalOrganic ChemistryLidocaineReversed-phase chromatographyAbsorption (skin)General MedicineHydrogen-Ion ConcentrationIbuprofenBiochemistryPermeabilityDosage formAnalytical Chemistrychemistry.chemical_compoundMicellar liquid chromatographyPermeability (electromagnetism)medicineSpectrophotometry UltravioletSalicylic acidChromatography Liquidmedicine.drugJournal of Chromatography A
researchProduct

Highly purified chondroitin sulfate: a literature review on clinical efficacy and pharmacoeconomic aspects in osteoarthritis treatment

2020

AbstractOsteoarthritis (OA) is the most prevalent musculoskeletal disease and a major cause of negative relevant outcomes, associated with an ever-increasing societal burden. Pharmaceutical-grade chondroitin sulfate (CS) was repeatedly reported to reduce pain and improve function in patients with OA. This article aims to review the evidence for the role of highly purified (hp) CS (Condrosulf®, IBSA) in the treatment of OA. We collected and reported evidence concerning (1) efficacy of hpCS 800 mg/day in the treatment of OA affecting the knee, hand and hip; (2) efficacy and safety of hpCS 1200 mg/day also in the oral gel formulation; (3) the safety profile of hpCS; (4) the difference of hpCS …

DrugAgingmedicine.medical_specialtyChondroitin sulfateKnee Jointmedia_common.quotation_subjectChondroitin sulfate · Osteoarthritis · Knee osteoarthritis · Hip osteoarthritis · Hand osteoarthritis · Economic analysisOsteoarthritisReviewChondroitin sulfate A03 medical and health scienceschemistry.chemical_compound0302 clinical medicineInternal medicineOsteoarthritisHand osteoarthritismedicineHumansIn patientHip osteoarthritis030212 general & internal medicineClinical efficacyChondroitin sulfateEconomics Pharmaceuticalmedia_common030203 arthritis & rheumatologybusiness.industryAnti-Inflammatory Agents Non-SteroidalChondroitin SulfatesEconomic analysisMusculoskeletal diseaseOsteoarthritis Kneemedicine.diseaseSafety profileTreatment Outcomechemistryembryonic structuresKnee osteoarthritisGeriatrics and Gerontologybusiness
researchProduct